CLINICAL EFFICACY OF THE SYNTHETIC ANTI-RHEUMATIC DRUG, IGURATIMOD

被引：0
|
作者：
Okamura, K. [1 ]
Yonemoto, Y. [1 ]
Okura, C. [1 ]
Kaneko, T. [1 ]
Kobayashi, T. [1 ]
Takagishi, K. [1 ]
机构：
[1] Gunma Univ, Grad Sch Med, Orthopaed Surg, Maebashi, Gunma 371, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2014年 / 73卷
关键词：
D O I：
10.1136/annrheumdis-2014-eular.4917
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0465
引用
收藏
页码：961 / 961
页数：1
相关论文
共 50 条
  • [1] A novel anti-rheumatic drug, iguratimod for RA - an initial clinical trial
    Xiao, Feng
    Zhang, Ling-ling
    Wei, Wei
    Xu, Jian-hua
    Li, Xing-fu
    Li, Xiang-pei
    Zhang, Miu-jia
    Deng, Jin-su
    Hu, Shao-xian
    Zhang, Feng-xiao
    Jia, Yun
    Wu, Cheng-yi
    Wang, Qing-tong
    Lu, Jing-tao
    Xu, Sheng-qian
    Wang, Guo-sheng
    Liu, Shuang
    Liu, Hua-xiang
    ACTA PHARMACOLOGICA SINICA, 2013, 34 : 41 - 42
  • [2] Pharmacological and clinical effect of T-614 (Iguratimod), an anti-rheumatic drug
    Tanaka, K
    Muramoto, K
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2004, 94 : 35P - 35P
  • [3] Iguratimod (T-614): a novel disease-modifying anti-rheumatic drug
    Tanaka, Keiichi
    RHEUMATOLOGY REPORTS, 2009, 1 (01) : 11 - 15
  • [4] Anti-allodynic action of the disease-modifying anti-rheumatic drug iguratimod in a rat model of neuropathic pain
    Morimoto, K.
    Miura, A.
    Tanaka, Keiichi
    INFLAMMATION RESEARCH, 2017, 66 (10) : 855 - 862
  • [5] Anti-allodynic action of the disease-modifying anti-rheumatic drug iguratimod in a rat model of neuropathic pain
    K. Morimoto
    A. Miura
    Keiichi Tanaka
    Inflammation Research, 2017, 66 : 855 - 862
  • [6] ANTI-RHEUMATIC DRUG-INTERACTIONS
    DAY, RO
    GRAHAM, GG
    CHAMPION, GD
    LEE, E
    CLINICS IN RHEUMATIC DISEASES, 1984, 10 (02): : 251 - 275
  • [7] Inhibitory Effect of Anti-rheumatic Drug Iguratimod for Hepatocellular Carcinogenesis by Inhibition of Serum Interleukin-8 Production
    Sakamoto, Taro
    Ishii, Yuji
    Shiba, Hiroaki
    Furukawa, Kenei
    Fujiwara, Yuki
    Haruki, Koichiro
    Iwase, Ryota
    Shirai, Yoshihiro
    Yanaga, Katsuhiko
    ANTICANCER RESEARCH, 2016, 36 (07) : 3301 - 3306
  • [8] CRITERIA OF THE EFFICACY OF ANTI-RHEUMATIC AGENTS IN CONTROLLED CLINICAL-TRIALS
    PAVELKA, K
    TERAPEVTICHESKII ARKHIV, 1982, 54 (06) : 106 - 109
  • [9] Anti-rheumatic drug iguratimod protects against cancer-induced bone pain and bone destruction in a rat model
    Sun, Yue
    Wu, Ying-Xing
    Zhang, Peng
    Peng, Guang
    Yu, Shi-Ying
    ONCOLOGY LETTERS, 2017, 13 (06) : 4849 - 4856
  • [10] COMPARATIVE EFFICACY OF NEW ANTI-RHEUMATIC AGENTS
    TSVETKOVA, ES
    SIGIDIN, YA
    TERAPEVTICHESKII ARKHIV, 1980, 52 (11) : 141 - 144
12345